Trial Profile
A multicenter, double-blind, placebo-controlled, parallel-group, phase 2b study of Finerenone assessing safety and efficacy in patients with type 2 diabetes and diabetic nephropathy: Arts-Dn
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Finerenone (Primary)
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 04 Mar 2016 New trial record